Chemoinformaics analysis of 3,5-DIHYDROXY-4-METHOXY-BENZOIC-ACID
Molecular Weight | 184.147 | nRot | 2 |
Heavy Atom Molecular Weight | 176.083 | nRig | 7 |
Exact Molecular Weight | 184.037 | nRing | 1 |
Solubility: LogS | -1.462 | nHRing | 0 |
Solubility: LogP | 0.996 | No. of Aliphatic Rings | 0 |
Acid Count | 1 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 1 |
nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 5 | No. of Arom Bond | 6 |
nHA | 4 | APOL | 22.7043 |
nHD | 3 | BPOL | 10.6297 |
QED | 0.632 |
Synth | 2.12 |
Natural Product Likeliness | 1.007 |
NR-PPAR-gamma | 0.008 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.001 |
Pgp-sub | 0.004 |
HIA | 0.019 |
CACO-2 | -5.466 |
MDCK | 0.00000706 |
BBB | 0.294 |
PPB | 0.512059 |
VDSS | 0.424 |
FU | 0.375737 |
CYP1A2-inh | 0.059 |
CYP1A2-sub | 0.493 |
CYP2c19-inh | 0.029 |
CYP2c19-sub | 0.047 |
CYP2c9-inh | 0.097 |
CYP2c9-sub | 0.104 |
CYP2d6-inh | 0.016 |
CYP2d6-sub | 0.127 |
CYP3a4-inh | 0.064 |
CYP3a4-sub | 0.037 |
CL | 7.587 |
T12 | 0.944 |
hERG | 0.03 |
Ames | 0.023 |
ROA | 0.02 |
SkinSen | 0.295 |
Carcinogencity | 0.03 |
EI | 0.973 |
Respiratory | 0.196 |
NR-Aromatase | 0.004 |
Antiviral | No |
Prediction | 0.875122 |